210 related articles for article (PubMed ID: 19574790)
1. Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.
Banys M; Solomayer EF; Becker S; Krawczyk N; Gardanis K; Staebler A; Neubauer H; Wallwiener D; Fehm T
Int J Gynecol Cancer; 2009 Jul; 19(5):948-52. PubMed ID: 19574790
[TBL] [Abstract][Full Text] [Related]
2. Detection of disseminated tumor cells in patients with gynecological cancers.
Fehm T; Becker S; Bachmann C; Beck V; Gebauer G; Banys M; Wallwiener D; Solomayer EF
Gynecol Oncol; 2006 Dec; 103(3):942-7. PubMed ID: 16889820
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients.
Walter CB; Taran FA; Wallwiener M; Rothmund R; Kraemer B; Krawczyk N; Blassl C; Melcher C; Wallwiener D; Fehm T; Hartkopf AD
Future Oncol; 2014 Jan; 10(1):41-8. PubMed ID: 24328408
[TBL] [Abstract][Full Text] [Related]
4. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
[TBL] [Abstract][Full Text] [Related]
5. Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
Fehm T; Banys M; Rack B; Janni W; Marth C; Blassl C; Hartkopf A; Trope C; Kimmig R; Krawczyk N; Wallwiener D; Wimberger P; Kasimir-Bauer S
Int J Gynecol Cancer; 2013 Jun; 23(5):839-45. PubMed ID: 23694981
[TBL] [Abstract][Full Text] [Related]
6. Disseminated tumor cells are not associated with established risk factors, L1CAM immunoreactivity and outcome in endometrial carcinoma.
Kommoss S; Hartkopf AD; Krämer B; Bunz AK; Grevenkamp F; Kommoss F; Pasternak J; Arbabi SM; Wallwiener M; Staebler A; Lax SF; Brucker SY; Taran FA
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2183-2188. PubMed ID: 28710714
[TBL] [Abstract][Full Text] [Related]
7. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580
[TBL] [Abstract][Full Text] [Related]
8. Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevance.
Wimberger P; Chebouti I; Kasimir-Bauer S; Lachmann R; Kuhlisch E; Kimmig R; Süleyman E; Kuhlmann JD
Gynecol Oncol; 2014 Jun; 133(3):467-72. PubMed ID: 24713547
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
[TBL] [Abstract][Full Text] [Related]
10. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
[TBL] [Abstract][Full Text] [Related]
12. The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy.
Hartkopf AD; Taran FA; Wallwiener M; Hagenbeck C; Melcher C; Krawczyk N; Hahn M; Wallwiener D; Fehm T
Breast Cancer Res; 2013; 15(5):R94. PubMed ID: 24099325
[TBL] [Abstract][Full Text] [Related]
13. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
[TBL] [Abstract][Full Text] [Related]
15. Detection and prevalence of disseminated tumor cells from the bone marrow of early stage male breast cancer patients.
Hartkopf AD; Taran FA; Walter CB; Hahn M; Fehm T; Wallwiener M; Brucker SY
Breast Cancer Res Treat; 2015 Jul; 152(1):51-55. PubMed ID: 26012646
[TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.
Roggel F; Hocke S; Lindemann K; Sinz S; Welk A; Bosl M; Pabst M; Nusser N; Braun S; Schmitt M; Harbeck N
Recent Results Cancer Res; 2003; 162():89-100. PubMed ID: 12790324
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
[TBL] [Abstract][Full Text] [Related]
18. [Detection of disseminated tumor cells in the bone marrow of breast cancer patients with a new molecular method].
Banyś M; Krawczyk N; Becker S; Becker-Pergola G; Banyś J; Krawczyk Z; Wallwiener D; Fehm T
Ginekol Pol; 2012 Aug; 83(8):590-7. PubMed ID: 23342882
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
[TBL] [Abstract][Full Text] [Related]
20. Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer.
Gruber I; Fehm T; Taran FA; Wallwiener M; Hahn M; Wallwiener D; Krawzyck N; Hoffmann J; Hartkopf AD
Breast Cancer Res Treat; 2014 Apr; 144(2):353-60. PubMed ID: 24554386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
